In rheumatoid arthritis, the use of anti-TNF was associated with reducedrisk of cardiovascular events (RR 0.7, 95% CI 0.54 to 0.9; p<0.005), acutemyocardial infarction (AMI), stroke and MACE. Here, TNF is linked to rheumatoid arthritis.